Enveric Biosciences, Inc. (ENVB) vs Lexaria Bioscience Corp. (LEXX)
- Enveric Biosciences, Inc. ENVB 1.38 −0.72%
- Lexaria Bioscience Corp. LEXX 2.92 −2.34%
Enveric Biosciences, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. Enveric Biosciences, Inc. and Lexaria Bioscience Corp. are of similar size ($6.3M and $6.2M). Lexaria Bioscience Corp. grew revenue faster over the last twelve months: 9.08% against −13.9%. Across the 13 metrics below, Lexaria Bioscience Corp. leads on 8 and Enveric Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | ENVB | LEXX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (235.48%) | (162.60%) | (56.36%) |
| Return on assets | (193.53%) | (134.20%) | (48.04%) |
| Return on invested capital | 0.00% | (662.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack